Advertisement

Heart Failure pp 267-270 | Cite as

Pulmonary Hypertension

  • Christoph B. WiedenrothEmail author
  • Eckhard Mayer
Chapter
Part of the Cardiovascular Medicine book series (CVM)

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH), representing group 4 of the classification of pulmonary hypertension (PH), is defined as a symptomatic PH with a mean pulmonary arterial pressure (PAm) of at least 25 mmHg and normal pulmonary arterial occlusion pressure (PAOP ≤15 mmHg) with pulmonary perfusion defects persisting after a 3 months episode of adequate anticoagulation [5]. Furthermore, there is a mechanical obstructive component, potentially amenable by surgery and a variable degree of secondary vasculopathy [10].

Notes

Disclosures

CB Wiedenroth has received speaker fees and/or consultant honoraria from Actelion, Bayer AG, BTG, MSD, and Pfizer.

E Mayer has received speaker fees and/or honoraria for consultations from Actelion, Bayer AG, GSK, MSD, and Pfizer.

References

  1. 1.
    Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99(19):1415–20.CrossRefGoogle Scholar
  2. 2.
    Cannon JE, Su L, Kiely DG, et al. dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71.CrossRefGoogle Scholar
  3. 3.
    Daily PO, Dembitsky WP, Iversen S. Technique of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Card Surg. 1989;4(1):10–24.CrossRefGoogle Scholar
  4. 4.
    Feinstein JA, Goldhaber SZ, Lock JE. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3.CrossRefGoogle Scholar
  5. 5.
    Galié N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75.CrossRefGoogle Scholar
  6. 6.
    Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29.CrossRefGoogle Scholar
  7. 7.
    Guérin L, Couturaud F, Parent F, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost. 2014;112(3):598–605.CrossRefGoogle Scholar
  8. 8.
    Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–62.CrossRefGoogle Scholar
  9. 9.
    Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62.CrossRefGoogle Scholar
  10. 10.
    Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009;54(1):67–77.CrossRefGoogle Scholar
  11. 11.
    Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D92–9.CrossRefGoogle Scholar
  12. 12.
    Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462–8.CrossRefGoogle Scholar
  13. 13.
    Lankeit M, Krieg V, Hobohm L, et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2017;37:250–8.  https://doi.org/10.1016/j.healun.2017.06.011.CrossRefGoogle Scholar
  14. 14.
    Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103.CrossRefGoogle Scholar
  15. 15.
    Mayer E. Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2010;19(115):64–7.CrossRefGoogle Scholar
  16. 16.
    Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10.CrossRefGoogle Scholar
  17. 17.
    Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Minerva Anestesiol. 2012;5(6):748–55.Google Scholar
  18. 18.
    Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21:425–31.CrossRefGoogle Scholar
  19. 19.
    Pengo V, Lensing A, Prins M, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. N Engl J Med. 2004;350:2257–64.CrossRefGoogle Scholar
  20. 20.
    Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81.CrossRefGoogle Scholar
  21. 21.
    Sato H, Ota H, Sugimura K, et al. Balloon pulmonary angioplasty improves biventricular functions and pulmonary flow in chronic thromboembolic pulmonary hypertension. Circ J. 2016;80(6):1470–7.CrossRefGoogle Scholar
  22. 22.
    Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–8.CrossRefGoogle Scholar
  23. 23.
    Taboada D, Pepke-Zaba J, Jenkins DP, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44:1635–45.CrossRefGoogle Scholar
  24. 24.
    Taniguchi Y, Miyagawa K, Nakayama K, et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014;10(4):518–25.CrossRefGoogle Scholar
  25. 25.
    Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery. Semin Thorac Cardiovasc Surg. 2006;18(3):257–64.CrossRefGoogle Scholar
  26. 26.
    Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988;94:1249–53.CrossRefGoogle Scholar
  27. 27.
    Wiedenroth CB, Liebetrau C, Breithecker A, et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2016;35(5):591–6.CrossRefGoogle Scholar
  28. 28.
    Wiedenroth CB, Olsson KM, Guth S, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulm Circ. 2018;  https://doi.org/10.1177/204589321775312.
  29. 29.
    Wiedenroth CB, Ghofrani HA, Adameit MSD. Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Pulm Circ. 2018; in press.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Thoracic SurgeryKerckhoff Heart and Thorax CenterBad NauheimGermany

Personalised recommendations